NIIMBL and Open Applications Group (OAGi) partner to develop open-source biopharmaceutical manufacturing ontologies
NIIMBL has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project.
NIIMBL collaborates on review of vaccine process technology developments
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published “Vaccine process technology—a decade of progress” in Biotechnology and Bioengineering. The paper serves as an update to a 2012 review titled “Vaccine process technology” authored by NIIMBL Executive Director Barry Buckland and explores transformations in vaccine development over the past decade.
NIIMBL announces 63 students for the 2024 NIIMBL eXperience
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NIIMBL eXperience
NIIMBL Hosts First-of-its-kind Biopharma Talent Partnership Event
NEWARK, Del., April 9, 2024 — NIIMBL hosts the U.S. Biopharma Workforce Partnership Conference, a first-of-its-kind event focused on strengthening talent pipelines.
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
NEWARK, Del., April 9, 2024 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $10M in planned project activities through the Institute’s Project Call 7.1 for eight new technology and workforce development projects that will help address key opportunities for innovation in biopharmaceutical manufacturing.
NIIMBL Is Now Accepting Applications for the 2024 NIIMBL eXperience Cohort
Newark, Del., October 17, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded approximately $500k in funding to launch the 2024 NIIMBL eXperience program in five locations across the United States. The application period is now open for the following locations: Albany College of Pharmacy and Health Sciences (ACPHS)- New York, Biomanufacturing Training Center at North Carolina State University, Thomas Jefferson University- Pennsylvania, Santa Clara University- California, and the…
NIIMBL Launches Viral Vector Program to Improve Access to AAV Gene Therapy
NEWARK, Del., October 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed to this effort with an ultimate vision to provide access to high quality viral vectors capable of serving the full spectrum of patient need, from prevalent indications to ultra-rare diseases, without cost or…
NIIMBL awards $370K for 5 eXperience programs in 2024
NIIMBL is pleased to announce it has awarded $370K to launch five NIIMBL eXperience programs next summer. These host locations represent distinct regions across the country. Each location will host a week-long program, designed to introduce Black, Latinx, and Indigenous college students to career possibilities in the biopharmaceutical industry. The 2024 NIIMBL eXperience host locations are…
NIIMBL Announces RFI for Next-Generation Sequencing Method Development Study
NEWARK, Del., August 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Information (RFI) related to a planned method development study, focused on the development and optimization of Next-Generation Sequencing (NGS) methods for extended characterization of Adeno-Associated Virus (AAV) gene therapy…
NIIMBL Announces New Funding Opportunities
NEWARK, Del., June 8, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $4M in funding through Project Call (PC) 7.1 and an additional $500k in funding for prospective regional leads for the 2024 NIIMBL eXperience Program. The PC7.1 Request for Proposals (RFP) and the 2024 NIIMBL eXperience Requests for Applications (RFA)…
NIIMBL Selects Largest eXperience Program Cohort to Date
Newark, Del., April 25, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to participate in the 2023 NIIMBL eXperience Program, the largest cohort to date since the program launched in 2019. Students were selected from 34 educational institutions across the United States to attend one of three cohorts hosted at Albany College of Pharmacy and Health Sciences (ACPHS) in New York, Kansas Bioscience Association (BioKansas) in the Kansas/Missouri Region, and Raritan Valley Community College in New Jersey. The program aims to introduce Black, Latinx, and Indigenous students to the biopharmaceutical manufacturing industry to ultimately increase the diversity of the school-to-industry pipeline and to build a workforce…
NIIMBL Addresses Talent Pipeline Through Industry and Comm College Collaboration
NEWARK, Del., March 28, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Part II of a whitepaper series titled Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a series focused on highlighting non-traditional and novel solutions for the talent pipeline gap in the biopharmaceutical industry. The newest whitepaper focuses on successes and challenges faced by community college biotechnology degree programs and makes the case for stronger engagement between…